Altace and Integrilin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Altace (ramipril) and Integrilin (eptifibatide). Common drug interactions include ejection fraction decreased among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Altace and Integrilin. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Integrilin?

Integrilin has active ingredients of eptifibatide. eHealthMe is studying from 3,037 Integrilin users. Check the latest studies of Integrilin.



On Jul, 17, 2026

45 people who take Altace and Integrilin together, and have interactions are studied.

Altace and Integrilin drug interactions.

What are the common drug interactions of Altace and Integrilin, by gender? *:

female:

  1. Ejection fraction decreased (systolic heart failure)
  2. Haematoma (collection of blood outside the blood vessels)
  3. Headache (pain in head)
  4. Hypotension (abnormally low blood pressure)
  5. Injury
  6. Pain
  7. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  8. Abdominal pain
  9. Anaemia (lack of blood)
  10. Anaphylactic reaction (serious allergic reaction)

male:

  1. Renal failure (kidney dysfunction)
  2. Injury
  3. Multi-organ failure (multisystem organ failure)
  4. Stress
  5. Cardiac failure congestive
  6. Chest pain
  7. Depressed level of consciousness
  8. Depression
  9. Headache (pain in head)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Altace and Integrilin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Injury
  3. Pain
  4. Psychiatric symptom
  5. Renal failure (kidney dysfunction)

40-49:

  1. Chest pain
  2. Non-cardiac chest pain
  3. Abnormal behaviour
  4. Acute myocardial infarction (acute heart attack)
  5. Alcohol abuse
  6. Aphthous stomatitis (mouth ulcer)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

50-59:

  1. Drug ineffective
  2. Electrocardiogram st segment depression
  3. Epistaxis (bleed from the nose)
  4. Groin pain
  5. Hepatomegaly (abnormal enlargement of the liver)
  6. Hypersensitivity
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Injection site pain
  9. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  10. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Renal failure (kidney dysfunction)
  2. Injury
  3. Fear
  4. Catheter site haemorrhage (bleeding at catheter site)
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Petechiae (a small red or purple spot caused by bleeding into the skin)
  8. Atrioventricular block (heart block)
  9. Multi-organ failure (multisystem organ failure)
  10. Stress

What are the existing conditions these people have? *

  1. Percutaneous Coronary Intervention: 3 people, 6.67%
  2. Diabetes: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and Integrilin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Altace and Integrilin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Integrilin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Altace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Integrilin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ramipril and eptifibatide (the active ingredients of Altace and Integrilin, respectively), and Altace and Integrilin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: